MyChesCo on MSN
AstraZeneca rings NYSE bell, eyes $80B revenue ambition
WILMINGTON, DE — AstraZeneca began trading its ordinary shares on the New York Stock Exchange on Monday, February 2, 2026, marking a significant milestone as the global biopharmaceutical giant expands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results